{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T11:25:26Z","timestamp":1768821926532,"version":"3.49.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundations of China","doi-asserted-by":"crossref","award":["81673379"],"award-info":[{"award-number":["81673379"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundations of China","doi-asserted-by":"crossref","award":["81373356"],"award-info":[{"award-number":["81373356"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Shanghai Science and Technology Innovation Action Plan","award":["14JC1493200"],"award-info":[{"award-number":["14JC1493200"]}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.xphs.2017.05.029","type":"journal-article","created":{"date-parts":[[2017,5,30]],"date-time":"2017-05-30T06:16:13Z","timestamp":1496124973000},"page":"3120-3130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Self-Assembled Core-Shell-Type Lipid-Polymer Hybrid Nanoparticles: Intracellular Trafficking and Relevance for Oral Absorption"],"prefix":"10.1016","volume":"106","author":[{"given":"Qiuxia","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dengning","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinsong","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aijun","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Gan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.xphs.2017.05.029_bib1","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1007\/s11095-008-9763-4","article-title":"Design of biodegradable nanoparticles for oral delivery of doxorubicin: in\u00a0vivo pharmacokinetics and toxicity studies in rats","volume":"26","author":"Kalaria","year":"2009","journal-title":"Pharm Res"},{"issue":"2","key":"10.1016\/j.xphs.2017.05.029_bib2","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jconrel.2007.02.004","article-title":"PLGA nanoparticles for oral delivery of cyclosporine: nephrotoxicity and pharmacokinetic studies in comparison to Sandimmune Neoral","volume":"119","author":"Italia","year":"2007","journal-title":"J\u00a0Control Release"},{"issue":"6","key":"10.1016\/j.xphs.2017.05.029_bib3","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.addr.2007.10.014","article-title":"Enhancing intestinal drug solubilisation using lipid-based delivery systems","volume":"60","author":"Porter","year":"2008","journal-title":"Adv Drug Deliv Rev"},{"issue":"1-2","key":"10.1016\/j.xphs.2017.05.029_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2013.04.002","article-title":"Comparative study of Pluronic((R)) F127-modified liposomes and chitosan-modified liposomes for mucus penetration and oral absorption of cyclosporine A in rats","volume":"449","author":"Chen","year":"2013","journal-title":"Int J Pharm"},{"issue":"1-2","key":"10.1016\/j.xphs.2017.05.029_bib5","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ijpharm.2009.10.018","article-title":"Polymer-based nanocapsules for drug delivery","volume":"385","author":"Mora-Huertas","year":"2010","journal-title":"Int J Pharm"},{"issue":"4","key":"10.1016\/j.xphs.2017.05.029_bib6","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.nano.2012.11.010","article-title":"Core-shell-type lipid-polymer hybrid nanoparticles as a drug delivery platform","volume":"9","author":"Mandal","year":"2013","journal-title":"Nanomedicine"},{"issue":"5","key":"10.1016\/j.xphs.2017.05.029_bib7","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.nano.2014.03.006","article-title":"Hybrid lipid-polymer nanoparticles for sustained siRNA delivery and gene silencing","volume":"10","author":"Shi","year":"2014","journal-title":"Nanomedicine"},{"issue":"8","key":"10.1016\/j.xphs.2017.05.029_bib8","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1021\/nn800275r","article-title":"Self-assembled lipid\u2013polymer hybrid nanoparticles: a robust drug delivery platform","volume":"2","author":"Zhang","year":"2008","journal-title":"ACS Nano"},{"issue":"9","key":"10.1016\/j.xphs.2017.05.029_bib9","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.tibtech.2012.04.008","article-title":"Colloidal systems for drug delivery: from design to therapy","volume":"30","author":"Beija","year":"2012","journal-title":"Trends Biotechnol"},{"issue":"1","key":"10.1016\/j.xphs.2017.05.029_bib10","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jconrel.2008.02.014","article-title":"Molecular interactions, internal structure and drug release kinetics of rationally developed polymer-lipid hybrid nanoparticles","volume":"128","author":"Li","year":"2008","journal-title":"J\u00a0Control Release"},{"issue":"3","key":"10.1016\/j.xphs.2017.05.029_bib11","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jconrel.2006.09.007","article-title":"Simultaneous delivery of doxorubicin and GG918 (Elacridar) by new Polymer-Lipid Hybrid Nanoparticles (PLN) for enhanced treatment of multidrug-resistant breast cancer","volume":"116","author":"Wong","year":"2006","journal-title":"J\u00a0Control Release"},{"issue":"34","key":"10.1016\/j.xphs.2017.05.029_bib12","doi-asserted-by":"crossref","first-page":"13803","DOI":"10.1073\/pnas.1305882110","article-title":"Unique insights into the intestinal absorption, transit, and subsequent biodistribution of polymer-derived microspheres","volume":"110","author":"Reineke","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.xphs.2017.05.029_bib13","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1023\/B:PHAM.0000022411.47059.76","article-title":"The characteristics and mechanisms of uptake of PLGA nanoparticles in rabbit conjunctival epithelial cell layers","volume":"21","author":"Qaddoumi","year":"2004","journal-title":"Pharm Res"},{"issue":"3","key":"10.1016\/j.xphs.2017.05.029_bib14","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0169-409X(02)00228-4","article-title":"Biodegradable nanoparticles for drug and gene delivery to cells and tissue","volume":"55","author":"Panyam","year":"2003","journal-title":"Adv Drug Deliv Rev"},{"issue":"11","key":"10.1016\/j.xphs.2017.05.029_bib15","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1023\/A:1012126301290","article-title":"The mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependent","volume":"14","author":"Desai","year":"1997","journal-title":"Pharm Res"},{"issue":"6","key":"10.1016\/j.xphs.2017.05.029_bib16","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1007\/s11095-009-9841-2","article-title":"Biodegradable nanoparticles improve oral bioavailability of amphotericin B and show reduced nephrotoxicity compared to intravenous Fungizone","volume":"26","author":"Italia","year":"2009","journal-title":"Pharm Res"},{"issue":"2","key":"10.1016\/j.xphs.2017.05.029_bib17","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jconrel.2009.08.010","article-title":"Lipid nanocarriers improve paclitaxel transport throughout human intestinal epithelial cells by using vesicle-mediated transcytosis","volume":"140","author":"Roger","year":"2009","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.xphs.2017.05.029_bib18","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.cis.2013.10.013","article-title":"Exocytosis of nanoparticles from cells: role in cellular retention and toxicity","volume":"201-202","author":"Sakhtianchi","year":"2013","journal-title":"Adv Colloid Interface Sci"},{"issue":"9","key":"10.1016\/j.xphs.2017.05.029_bib19","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1021\/mp300293n","article-title":"Endocytosis and intracellular trafficking as gateways for nanomedicine delivery: opportunities and challenges","volume":"9","author":"Duncan","year":"2012","journal-title":"Mol Pharm"},{"issue":"6","key":"10.1016\/j.xphs.2017.05.029_bib20","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/nrm3588","article-title":"Organization of the ER-Golgi interface for membrane traffic control","volume":"14","author":"Brandizzi","year":"2013","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"3","key":"10.1016\/j.xphs.2017.05.029_bib21","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.cocis.2010.11.005","article-title":"Poly(lactide-co-glycolide) nanoparticles for peroral delivery of bioactives","volume":"16","author":"Grama","year":"2011","journal-title":"Curr Opin Colloid Interf Sci"},{"issue":"19","key":"10.1016\/j.xphs.2017.05.029_bib22","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1016\/j.biomaterials.2009.02.045","article-title":"Poly(lactide)-vitamin E derivative\/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel","volume":"30","author":"Feng","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.xphs.2017.05.029_bib23","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ejps.2014.04.014","article-title":"Enhanced bioavailability and intestinal uptake of Gemcitabine HCl loaded PLGA nanoparticles after oral delivery","volume":"60","author":"Joshi","year":"2014","journal-title":"Eur J Pharm Sci"},{"issue":"5","key":"10.1016\/j.xphs.2017.05.029_bib24","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1007\/s11095-007-9473-3","article-title":"An examination of the effect of intestinal first pass extraction on intestinal lymphatic transport of saquinavir in the rat","volume":"25","author":"Griffin","year":"2008","journal-title":"Pharm Res"},{"issue":"3","key":"10.1016\/j.xphs.2017.05.029_bib25","doi-asserted-by":"crossref","first-page":"461","DOI":"10.2165\/00003495-199855030-00014","article-title":"Saquinavir soft-gel capsule formulation\u2014a review of its use in patients with HIV infection","volume":"55","author":"Perry","year":"1998","journal-title":"Drugs"},{"key":"10.1016\/j.xphs.2017.05.029_bib26","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/aps.2015.53","article-title":"Enhancement of cellular uptake, transport and oral absorption of protease inhibitor saquinavir by nanocrystal formulation","volume":"36","author":"He","year":"2015","journal-title":"Acta Pharmacol Sin"},{"issue":"1-3","key":"10.1016\/j.xphs.2017.05.029_bib27","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0169-409X(99)00022-8","article-title":"P-glycoprotein, secretory transport, and other barriers to the oral delivery of anti-HIV drugs","volume":"39","author":"Aungst","year":"1999","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"10.1016\/j.xphs.2017.05.029_bib28","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ejpb.2011.08.005","article-title":"Preparation and solid-state characterization of ball milled saquinavir mesylate for solubility enhancement","volume":"80","author":"Branham","year":"2012","journal-title":"Eur J Pharm Biopharm"},{"issue":"2","key":"10.1016\/j.xphs.2017.05.029_bib29","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/jps.23830","article-title":"Design of lipid matrix particles for fenofibrate: effect of polymorphism of glycerol monostearate on drug incorporation and release","volume":"103","author":"Xia","year":"2014","journal-title":"J\u00a0Pharm Sci"},{"issue":"25","key":"10.1016\/j.xphs.2017.05.029_bib30","doi-asserted-by":"crossref","first-page":"6082","DOI":"10.1016\/j.biomaterials.2013.04.053","article-title":"The transport mechanisms of polymer nanoparticles in Caco-2 epithelial cells","volume":"34","author":"He","year":"2013","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.xphs.2017.05.029_bib31","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jconrel.2012.12.021","article-title":"Mechanism of transport of saquinavir-loaded nanostructured lipid carriers across the intestinal barrier","volume":"166","author":"Beloqui","year":"2013","journal-title":"J\u00a0Control Release"},{"issue":"17","key":"10.1016\/j.xphs.2017.05.029_bib32","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1016\/j.biomaterials.2013.01.100","article-title":"The transport pathways of polymer nanoparticles in MDCK epithelial cells","volume":"34","author":"He","year":"2013","journal-title":"Biomaterials"},{"issue":"4","key":"10.1016\/j.xphs.2017.05.029_bib33","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1083\/jcb.200908086","article-title":"Amiloride inhibits macropinocytosis by lowering submembranous pH and preventing Rac1 and Cdc42 signaling","volume":"188","author":"Koivusalo","year":"2010","journal-title":"J\u00a0Cell Biol"},{"issue":"1-2","key":"10.1016\/j.xphs.2017.05.029_bib34","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ijpharm.2015.02.063","article-title":"Microfluidic-controlled manufacture of liposomes for the solubilisation of a poorly water soluble drug","volume":"485","author":"Kastner","year":"2015","journal-title":"Int J Pharm"},{"issue":"3","key":"10.1016\/j.xphs.2017.05.029_bib35","doi-asserted-by":"crossref","first-page":"408","DOI":"10.2174\/13816128113199990397","article-title":"Application of precipitation methods for the production of water-insoluble drug nanocrystals: production techniques and stability of nanocrystals","volume":"20","author":"Xia","year":"2014","journal-title":"Curr Pharm Des"},{"issue":"6","key":"10.1016\/j.xphs.2017.05.029_bib36","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.addr.2011.04.005","article-title":"Controlling drug nanoparticle formation by rapid precipitation","volume":"63","author":"D'Addio","year":"2011","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.xphs.2017.05.029_bib37","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.addr.2016.01.007","article-title":"Impact of particle elasticity on particle-based drug delivery systems","volume":"108","author":"Anselmo","year":"2017","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.xphs.2017.05.029_bib38","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cis.2015.01.007","article-title":"Understanding nanoparticle cellular entry: a physicochemical perspective","volume":"218","author":"Beddoes","year":"2015","journal-title":"Adv Colloid Interface Sci"},{"issue":"8","key":"10.1016\/j.xphs.2017.05.029_bib39","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1002\/adma.201404788","article-title":"Tunable rigidity of (polymeric core)-(lipid shell) nanoparticles for regulated cellular uptake","volume":"27","author":"Sun","year":"2015","journal-title":"Adv Mater"},{"issue":"6633","key":"10.1016\/j.xphs.2017.05.029_bib40","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/42408","article-title":"Functional rafts in cell membranes","volume":"387","author":"Simons","year":"1997","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.xphs.2017.05.029_bib41","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2217\/nnm.09.110","article-title":"Biopharmaceutical parameters to consider in order to alter the fate of nanocarriers after oral delivery","volume":"5","author":"Roger","year":"2010","journal-title":"Nanomedicine (Lond)"},{"issue":"5","key":"10.1016\/j.xphs.2017.05.029_bib42","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.drudis.2016.04.007","article-title":"Intracellular transport of nanocarriers across the intestinal epithelium","volume":"21","author":"Fan","year":"2016","journal-title":"Drug Discov Today"},{"issue":"11","key":"10.1016\/j.xphs.2017.05.029_bib43","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1034\/j.1600-0854.2003.00128.x","article-title":"Lipid rafts and caveolae as portals for endocytosis: new insights and common mechanisms","volume":"4","author":"Parton","year":"2003","journal-title":"Traffic"},{"issue":"1","key":"10.1016\/j.xphs.2017.05.029_bib44","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/35036052","article-title":"Lipid rafts and signal transduction","volume":"1","author":"Simons","year":"2000","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"8","key":"10.1016\/j.xphs.2017.05.029_bib45","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nrm2216","article-title":"Pathways of clathrin-independent endocytosis","volume":"8","author":"Mayor","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"3","key":"10.1016\/j.xphs.2017.05.029_bib46","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jconrel.2010.01.036","article-title":"Endocytosis of nanomedicines","volume":"145","author":"Sahay","year":"2010","journal-title":"J\u00a0Control Release"},{"issue":"10","key":"10.1016\/j.xphs.2017.05.029_bib47","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1021\/mp5004674","article-title":"Transport pathways of solid lipid nanoparticles across madin-darby canine kidney epithelial cell monolayer","volume":"11","author":"Chai","year":"2014","journal-title":"Mol Pharm"},{"issue":"8","key":"10.1016\/j.xphs.2017.05.029_bib48","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1111\/j.1600-0854.2011.01188.x","article-title":"Physiology and pathology of endosome-to-Golgi retrograde sorting","volume":"12","author":"Burd","year":"2011","journal-title":"Traffic"},{"key":"10.1016\/j.xphs.2017.05.029_bib49","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1146\/annurev-physiol-021909-135801","article-title":"The biogenesis of chylomicrons","volume":"72","author":"Mansbach","year":"2010","journal-title":"Annu Rev Physiol"},{"issue":"11","key":"10.1016\/j.xphs.2017.05.029_bib50","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.addr.2003.07.004","article-title":"Mechanisms of TfR-mediated transcytosis and sorting in epithelial cells and applications toward drug delivery","volume":"55","author":"Widera","year":"2003","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"10.1016\/j.xphs.2017.05.029_bib51","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1152\/physrev.00001.2003","article-title":"Transcytosis: crossing cellular barriers","volume":"83","author":"Tuma","year":"2003","journal-title":"Physiol Rev"},{"issue":"3","key":"10.1016\/j.xphs.2017.05.029_bib52","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nrm1593","article-title":"Organization of vesicular trafficking in epithelia","volume":"6","author":"Rodriguez-Boulan","year":"2005","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"4","key":"10.1016\/j.xphs.2017.05.029_bib53","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1600-0854.2004.0162.x","article-title":"Lipid rafts and the regulation of exocytosis","volume":"5","author":"Salaun","year":"2004","journal-title":"Traffic"},{"issue":"3","key":"10.1016\/j.xphs.2017.05.029_bib54","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nrd2197","article-title":"Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs","volume":"6","author":"Porter","year":"2007","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"10.1016\/j.xphs.2017.05.029_bib55","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ddtec.2005.05.019","article-title":"Nanoparticle uptake by the oral route: fulfilling its potential?","volume":"2","author":"Florence","year":"2005","journal-title":"Drug Discov Today Tech"},{"issue":"2","key":"10.1016\/j.xphs.2017.05.029_bib56","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0928-0987(97)10007-0","article-title":"Binding and uptake of biodegradable poly-DL-lactide micro- and nanoparticles in intestinal epithelia","volume":"6","author":"McClean","year":"1998","journal-title":"Eur J Pharm Sci"},{"issue":"12","key":"10.1016\/j.xphs.2017.05.029_bib57","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1023\/A:1016085108889","article-title":"Gastrointestinal uptake of biodegradable microparticles: effect of particle size","volume":"13","author":"Desai","year":"1996","journal-title":"Pharm Res"},{"issue":"3","key":"10.1016\/j.xphs.2017.05.029_bib58","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.jconrel.2013.05.043","article-title":"Can bioadhesive nanoparticles allow for more effective particle uptake from the small intestine?","volume":"170","author":"Reineke","year":"2013","journal-title":"J\u00a0Control Release"},{"issue":"6","key":"10.1016\/j.xphs.2017.05.029_bib59","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.addr.2013.01.002","article-title":"Targeted nanoparticles with novel non-peptidic ligands for oral delivery","volume":"65","author":"des Rieux","year":"2013","journal-title":"Adv Drug Deliv Rev"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354917303866?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354917303866?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,4,4]],"date-time":"2021-04-04T21:14:30Z","timestamp":1617570870000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354917303866"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":59,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S0022354917303866"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2017.05.029","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Self-Assembled Core-Shell-Type Lipid-Polymer Hybrid Nanoparticles: Intracellular Trafficking and Relevance for Oral Absorption","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2017.05.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}